Advertisement
Singapore markets closed

  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     

  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • Bitcoin USD

    60,458.78
    -2,263.50 (-3.61%)
     

  • CMC Crypto 200

    1,302.78
    -55.23 (-4.22%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • Dow

    39,512.84
    +125.08 (+0.32%)
     

  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     

  • Gold

    2,366.90
    +26.60 (+1.14%)
     

  • Crude Oil

    78.20
    -1.06 (-1.34%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Bayer reports $4.35 billion full-year net profit

Bayer's full-year net profit jumps by a third to $4.35 billion as sales hit record high

Associated Press

BERLIN (AP) -- Bayer AG says its net profit jumped by almost a third last year to 3.19 billion euros ($4.35 billion) as sales hit a record high.

This compares with a net profit of 2.91 billion euros in 2012. Fourth-quarter net profits rose 24 percent to 455 million euros.

The German drug and chemical company says revenues reached 40.16 billion euros in 2013, an increase of about 1 percent year-on-year.

Board chairman Marijn Dekkers said Friday that the Leverkusen-based company expects sales of 41-42 billion euros in 2014.

The company announced Thursday that it is buying Dihon Pharmaceutical Group Co., a manufacturer of over-the-counter medicines and Chinese herbal products, for an undisclosed sum.

Bayer shares rose 0.8 percent to 100.65 euros in early trading on the Frankfurt exchange.